In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery

Turkoglu M., Ugurlu T.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, vol.53, no.1, pp.65-73, 2002 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 53 Issue: 1
  • Publication Date: 2002
  • Doi Number: 10.1016/s0939-6411(01)00225-9
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.65-73
  • Keywords: colonic delivery, 5-aminosalicylic acid, pectin, HPMC, compression coating, pectinase, DRUG-DELIVERY, IN-VITRO, SYSTEM, SPECIFICITY, POLYMERS, CARRIER, RELEASE
  • Istanbul Technical University Affiliated: Yes


In this study, we report pectin-HPMC compression coated core tablets of 5-aminosalicylic acid (5-ASA) for colonic delivery. Each 100 mg core tablet contained 5-ASA and was compression coated at 20 kN or 30 kN using 100% pectin, 80% pectin-20% HPMC, or 60% pectin-40% HPMC, at two different coat weights as 400 or 500 mg. Drug dissolution/system erosion/degradation studies were carried out in pH 1.2 and 6.8 buffers using a pectinolytic enzyme. The system was designed based on the gastrointestinal transit time concept, under the assumption of colon arrival times of 6 h. It was found that pectin alone was not sufficient to protect the core tablets and HPMC addition was required to control the solubility of pectin. The optimum HPMC concentration was 20% and such system would protect the cores up to 6 In that corresponded to 25-35% erosion and after that under the influence of pectinase the system would degrade faster and delivering 5-ASA to the colon. The pectin-HPMC envelope was found to be a promising drug delivery system for those drugs to be delivered to the colon. (C) 2002 Elsevier Science B.V. All rights reserved.